• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

葛根素通过抑制 LPS 诱导的 RAW264.7 巨噬细胞中 NF-κB 的激活来抑制 iNOS、COX-2 和 CRP 的表达。

Puerarin inhibits iNOS, COX-2 and CRP expression via suppression of NF-κB activation in LPS-induced RAW264.7 macrophage cells.

机构信息

Department of Cardiology, First Affiliated Hospital of Soochow University, Soochow, China.

出版信息

Pharmacol Rep. 2011;63(3):781-9. doi: 10.1016/s1734-1140(11)70590-4.

DOI:10.1016/s1734-1140(11)70590-4
PMID:21857089
Abstract

Puerarin (7,4'-dihydroxy-8-C-glucosylisoflavone) is the most abundant isoflavone-C-glucoside extracted from Radix puerariae, and it has been used for various medicinal purposes in traditional oriental medicine for thousands of years. In the present study, the ability of the puerarin to modulate inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2) and C reactive protein (CRP) expression and induce changes in the nuclear factor κB (NF-κB) pathway in RAW264.7 macrophage cells was examined. The protein and mRNA levels of lipopolysaccharide (LPS)-induced iNOS, COX-2 and CRP were determined in RAW246.7 macrophage cells. Inhibitor κB (I-κB) phosphorylation and p65NF-κB expression in RAW246.7 macrophage cells were also detected under our experimental conditions. The results indicated that puerarin inhibited the expression of LPS-induced iNOS, COX-2 and CRP proteins and also suppressed their mRNAs from RT-PCR experiments in RAW264.7 cells. Subsequently, we determined that the inhibition of iNOS, COX-2 and CRP expression was due to a dose-dependent inhibition of phosphorylation and degradation of I-κB, which resulted in the reduction of p65NF-κB nuclear translocation. These data suggested that the effect of puerarin-mediated inhibition of LPS-induced iNOS, COX-2 and CRP expression is attributed to suppressed NF-κB activation at the transcriptional level.

摘要

葛根素(7,4'-二羟基-8-C-葡萄糖基异黄酮)是从葛根中提取的最丰富的异黄酮-C-葡萄糖苷,在传统东方医学中已有数千年用于各种药用目的。在本研究中,研究了葛根素调节诱导型一氧化氮合酶(iNOS)、环氧化酶-2(COX-2)和 C 反应蛋白(CRP)表达的能力,并诱导 RAW264.7 巨噬细胞中核因子κB(NF-κB)途径的变化。在 RAW246.7 巨噬细胞中测定了脂多糖(LPS)诱导的 iNOS、COX-2 和 CRP 的蛋白和 mRNA 水平。在我们的实验条件下,还检测了 RAW246.7 巨噬细胞中抑制剂κB(I-κB)磷酸化和 p65NF-κB 表达。结果表明,葛根素抑制 LPS 诱导的 iNOS、COX-2 和 CRP 蛋白的表达,并通过 RAW264.7 细胞中的 RT-PCR 实验抑制其 mRNAs。随后,我们确定 iNOS、COX-2 和 CRP 表达的抑制是由于 I-κB 的磷酸化和降解的剂量依赖性抑制,导致 p65NF-κB 核易位减少。这些数据表明,葛根素介导的 LPS 诱导的 iNOS、COX-2 和 CRP 表达抑制作用归因于转录水平抑制 NF-κB 激活。

相似文献

1
Puerarin inhibits iNOS, COX-2 and CRP expression via suppression of NF-κB activation in LPS-induced RAW264.7 macrophage cells.葛根素通过抑制 LPS 诱导的 RAW264.7 巨噬细胞中 NF-κB 的激活来抑制 iNOS、COX-2 和 CRP 的表达。
Pharmacol Rep. 2011;63(3):781-9. doi: 10.1016/s1734-1140(11)70590-4.
2
Puerarin inhibits C-reactive protein expression via suppression of nuclear factor kappaB activation in lipopolysaccharide-induced peripheral blood mononuclear cells of patients with stable angina pectoris.葛根素通过抑制核因子 kappaB 的激活抑制稳定型心绞痛患者脂多糖诱导的外周血单个核细胞 C 反应蛋白的表达。
Basic Clin Pharmacol Toxicol. 2010 Aug;107(2):637-42. doi: 10.1111/j.1742-7843.2010.00548.x. Epub 2010 Mar 22.
3
Puerarin inhibits adhesion molecule expression in tnf-alpha-stimulated human endothelial cells via modulation of the nuclear factor kappaB pathway.葛根素通过调节核因子 kappaB 通路抑制 TNF-α 刺激的人内皮细胞黏附分子的表达。
Pharmacology. 2010;85(1):27-35. doi: 10.1159/000264938. Epub 2009 Dec 11.
4
Extractable and non-extractable polyphenols from blueberries modulate LPS-induced expression of iNOS and COX-2 in RAW264.7 macrophages via the NF-κB signalling pathway.蓝莓中可提取和不可提取的多酚通过NF-κB信号通路调节脂多糖诱导的RAW264.7巨噬细胞中诱导型一氧化氮合酶(iNOS)和环氧化酶-2(COX-2)的表达。
J Sci Food Agric. 2016 Aug;96(10):3393-400. doi: 10.1002/jsfa.7519. Epub 2015 Dec 29.
5
Puerarin exerts antipyretic effect on lipopolysaccharide-induced fever in rats involving inhibition of pyrogen production from macrophages.葛根素对脂多糖诱导的发热大鼠有解热作用,其机制与抑制巨噬细胞产热原有关。
J Ethnopharmacol. 2012 May 7;141(1):322-30. doi: 10.1016/j.jep.2012.02.038. Epub 2012 Feb 28.
6
Isoliquiritigenin isolated from the roots of Glycyrrhiza uralensis inhibits LPS-induced iNOS and COX-2 expression via the attenuation of NF-kappaB in RAW 264.7 macrophages.从甘草根中分离出的异甘草素通过减弱RAW 264.7巨噬细胞中的NF-κB来抑制脂多糖诱导的诱导型一氧化氮合酶(iNOS)和环氧化酶-2(COX-2)的表达。
Eur J Pharmacol. 2008 Apr 14;584(1):175-84. doi: 10.1016/j.ejphar.2008.01.032. Epub 2008 Feb 5.
7
Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-kappaB activation.木犀草素A通过抑制核因子-κB激活来抑制脂多糖诱导的诱导型一氧化氮合酶和环氧化酶-2基因表达。
Biochem Pharmacol. 2000 Jun 1;59(11):1445-57. doi: 10.1016/s0006-2952(00)00255-0.
8
Rhododendron album Blume inhibits iNOS and COX-2 expression in LPS-stimulated RAW264.7 cells through the downregulation of NF-κB signaling.白花杜鹃通过下调核因子κB信号通路抑制脂多糖刺激的RAW264.7细胞中诱导型一氧化氮合酶和环氧化酶-2的表达。
Int J Mol Med. 2015 Apr;35(4):987-94. doi: 10.3892/ijmm.2015.2107. Epub 2015 Feb 25.
9
Puerarin suppresses production of nitric oxide and inducible nitric oxide synthase in lipopolysaccharide-induced N9 microglial cells through regulating MAPK phosphorylation, O-GlcNAcylation and NF-κB translocation.葛根素通过调节 MAPK 磷酸化、O-GlcNAc 化和 NF-κB 易位抑制脂多糖诱导的 N9 小胶质细胞中一氧化氮和诱导型一氧化氮合酶的产生。
Int J Oncol. 2012 May;40(5):1610-8. doi: 10.3892/ijo.2012.1331. Epub 2012 Jan 13.
10
Inhibitory effect of sulphated polysaccharide porphyran on nitric oxide production in lipopolysaccharide-stimulated RAW264.7 macrophages.硫酸化多糖岩藻多糖对脂多糖刺激的 RAW264.7 巨噬细胞一氧化氮生成的抑制作用。
J Biochem. 2012 Jan;151(1):65-74. doi: 10.1093/jb/mvr115. Epub 2011 Oct 5.

引用本文的文献

1
Decreased Risk of Osteoporosis Incident in Subjects Receiving Chinese Herbal Medicine for Treatment: A Retrospective Cohort Study with a Nested Case-Control Analysis.接受中药治疗的受试者骨质疏松症发病风险降低:一项嵌套病例对照分析的回顾性队列研究。
Pharmaceuticals (Basel). 2024 Jun 6;17(6):745. doi: 10.3390/ph17060745.
2
The beneficial health effects of puerarin in the treatment of cardiovascular diseases: from mechanisms to therapeutics.葛根素在心血管疾病治疗中的有益健康作用:从机制到治疗。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7273-7296. doi: 10.1007/s00210-024-03142-3. Epub 2024 May 6.
3
Pelargonidin alleviates acrolein-induced inflammation in human umbilical vein endothelial cells by reducing COX-2 expression through the NF-κB pathway.
天竺葵素通过NF-κB途径降低COX-2表达,减轻丙烯醛诱导的人脐静脉内皮细胞炎症。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Mar;397(3):1737-1748. doi: 10.1007/s00210-023-02712-1. Epub 2023 Sep 20.
4
Study on the mechanism of puerarin against osteoarthritis from ferroptosis based on network pharmacology and bioinformatics.基于网络药理学和生物信息学研究葛根素防治骨关节炎的铁死亡机制。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Feb;397(2):959-968. doi: 10.1007/s00210-023-02653-9. Epub 2023 Aug 7.
5
Da-Yuan-Yin decoction polyphenol fraction attenuates acute lung injury induced by lipopolysaccharide.大元饮汤多酚部分减轻脂多糖诱导的急性肺损伤。
Pharm Biol. 2023 Dec;61(1):228-240. doi: 10.1080/13880209.2023.2166085.
6
Effect of natural polyphenols in Chinese herbal medicine on obesity and diabetes: Interactions among gut microbiota, metabolism, and immunity.中药中天然多酚对肥胖和糖尿病的影响:肠道微生物群、代谢和免疫之间的相互作用。
Front Nutr. 2022 Oct 28;9:962720. doi: 10.3389/fnut.2022.962720. eCollection 2022.
7
Study on the mechanism of Ginseng-Gegen for mesenteric lymphadenitis based on network pharmacology.基于网络药理学的人参-葛根治疗肠系膜淋巴结炎的机制研究
Transl Pediatr. 2022 Sep;11(9):1534-1543. doi: 10.21037/tp-22-386.
8
Network pharmacology-based strategy for predicting therapy targets of Sanqi and Huangjing in diabetes mellitus.基于网络药理学的三七和黄精治疗糖尿病靶点预测策略
World J Clin Cases. 2022 Jul 16;10(20):6900-6914. doi: 10.12998/wjcc.v10.i20.6900.
9
Puerarin Prevents Acute Liver Injury Inhibiting Inflammatory Responses and ZEB2 Expression.葛根素通过抑制炎症反应和ZEB2表达预防急性肝损伤。
Front Pharmacol. 2021 Aug 6;12:727916. doi: 10.3389/fphar.2021.727916. eCollection 2021.
10
Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.年龄相关性认知功能障碍管理中的潜在草药-药物相互作用。
Pharmaceutics. 2021 Jan 19;13(1):124. doi: 10.3390/pharmaceutics13010124.